|
Product Description
|
Recall Class
|
FDA Recall Posting Date
|
Recalling Firm
|
Z-0849-2023 - ETEST CLINICAL IMIPENEM RELEBACTAM IPR US S30, CATALOG 420927
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0826-2023 - ETEST CLINICAL LEVOFLOXACIN LE 32 US S30, CATALOG 412392
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0827-2023 - ETEST CLINICAL MEROPENEM MP 32 US S30, CATALOG 412401
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0828-2023 - ETEST CLINICAL MINOCYCLINE MC 256 US S30, CATALOG 412407
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0829-2023 - ETEST CLINICAL RIFAMPICIN RI 32 US S30, CATALOG 412449
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0830-2023 - ETEST CLINICAL TOBRAMYCIN TM 256 US S30, CATALOG 412478
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0831-2023 - ETEST CLINICAL VANCOMYCIN VA 256 US S30, CATALOG 412486
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0840-2023 - GENE-UP REAGENT GENE-UP LYSIS KIT, CATALOG 414057
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0855-2023 - GENE-UP REAGENT GENE-UP Salmonella 2, CATALOG 423105
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0802-2023 - PPM CLINICAL CHROMID MRSA 20 PLT US, CATALOG 43841
|
2
|
01/04/2023
|
Biomerieux Inc
|